NO912980L - Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater - Google Patents

Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater

Info

Publication number
NO912980L
NO912980L NO91912980A NO912980A NO912980L NO 912980 L NO912980 L NO 912980L NO 91912980 A NO91912980 A NO 91912980A NO 912980 A NO912980 A NO 912980A NO 912980 L NO912980 L NO 912980L
Authority
NO
Norway
Prior art keywords
carbapend
fluorenoyl
derivatives
preparing
procedure
Prior art date
Application number
NO91912980A
Other languages
English (en)
Other versions
NO912980D0 (no
Inventor
Mark L Greenlee
Frank P Dininno
Lovji D Cama
James V Heck
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/561,547 external-priority patent/US5034384A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO912980D0 publication Critical patent/NO912980D0/no
Publication of NO912980L publication Critical patent/NO912980L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nye forbindelser av formelen: (0-2) hvori R er H eller CH 3' er en 5- eller 6-leddet mono- syklisk heterosyklus eller en 8-, 9- eller 10-leddet bisyk- lisk heterosyklus, er hydrogen, C, .alkyl eller -NH7 (hvor ett eller begge av hydrogenatomene av aminet er erstattet med C, .alkyl), og bundet til karbonringatomet eller nitrogenheteroatomet hvis valens ikke er tilfredsstilt av ringbindingen; utviser tera- peutisk aktivitet. Fremstilling av forbindelsene er beskrevet.
NO91912980A 1990-08-01 1991-07-31 Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater NO912980L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/561,547 US5034384A (en) 1990-08-01 1990-08-01 2-(9-fluorenonyl)-carbapenem antibacterial agents
US59480890A 1990-10-09 1990-10-09

Publications (2)

Publication Number Publication Date
NO912980D0 NO912980D0 (no) 1991-07-31
NO912980L true NO912980L (no) 1992-02-03

Family

ID=27072675

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912980A NO912980L (no) 1990-08-01 1991-07-31 Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater

Country Status (11)

Country Link
EP (1) EP0472306A1 (no)
JP (1) JP2509771B2 (no)
KR (1) KR920004388A (no)
CA (1) CA2048269A1 (no)
FI (1) FI913655A7 (no)
IE (1) IE912709A1 (no)
IL (1) IL98911A0 (no)
MX (1) MX9100466A (no)
NO (1) NO912980L (no)
NZ (1) NZ239186A (no)
PT (1) PT98522A (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use
US5756725A (en) * 1996-04-24 1998-05-26 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
JP2001500862A (ja) * 1996-09-12 2001-01-23 メルク エンド カンパニー インコーポレーテッド カルバペネム系抗菌化合物、該化合物を含む組成物および治療方法
KR20020036905A (ko) * 2000-11-11 2002-05-17 황영헌 비정상 상태 제어장치 및 방법과 그 프로그램 소스를저장한 기록매체
US9296752B2 (en) 2010-07-08 2016-03-29 Hans R. Pfaendler Fluorescent carbapenems
KR102912122B1 (ko) * 2022-01-14 2026-01-14 엘에스일렉트릭(주) 이중계 시스템

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543257A (en) * 1977-10-19 1985-09-24 Merck & Co., Inc. 1-Carba-2-penem-3-carboxylic acid
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
US4600713A (en) * 1979-12-03 1986-07-15 Merck & Co., Inc. 1-, 6- and 2-substituted-1-carba-2-penem-3-carboxylic acids
EP0277743A1 (en) * 1987-02-02 1988-08-10 Merck & Co. Inc. 2-(heteroaryliumalkyl)phenyl carbapenem antibacterial agents

Also Published As

Publication number Publication date
NO912980D0 (no) 1991-07-31
JPH05105679A (ja) 1993-04-27
KR920004388A (ko) 1992-03-27
MX9100466A (es) 1992-04-01
EP0472306A1 (en) 1992-02-26
AU8151791A (en) 1992-02-06
FI913655A0 (fi) 1991-07-31
FI913655L (fi) 1992-02-02
PT98522A (pt) 1992-06-30
IE912709A1 (en) 1992-02-12
IL98911A0 (en) 1992-07-15
NZ239186A (en) 1993-12-23
JP2509771B2 (ja) 1996-06-26
CA2048269A1 (en) 1992-02-02
FI913655A7 (fi) 1992-02-02
AU642518B2 (en) 1993-10-21

Similar Documents

Publication Publication Date Title
IL103944A0 (en) Piperazine derivatives,their preparation and pharmaceutical compositions containing them
NO892058D0 (no) Fremgangsnaate for fremstilling av terapeutisk aktive benzamider.
ATE110076T1 (de) Verbindungen der 1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure.
NO177007C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tetrahydrobenzimidazolderivater
KR860005794A (ko) 이미다졸 유도체의 제조방법
SE8605504D0 (sv) Novel chroman derivatives
ES8704445A1 (es) Procedimiento de preparar derivados aminicos
DE68917357D1 (de) Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.
NO168418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser
DK147588A (da) Benzoxazinderivat samt fremgangsmaade til fremstilling deraf
FR2355797A1 (fr) Procede de preparation de vinylcyclopropanes substitues utilisables dans la preparation d'insecticides
NO170215C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
DK474089A (da) Indolderivater og fremgangsmaader til fremstilling deraf
HUT50176A (en) Process for production of derivatives of heterocyclic lactane and medical compositions containing them as active substance
ATE34173T1 (de) Thiazolderivate als h2-rezeptor-antagonisten.
NO179445C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksysulfonylkarbamater
HU913293D0 (en) Process for the production of pierazine derivatives and medical preparations containing them
NO177494C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive alkylaminoalkylamin- og -eter-forbindelser
AU4583489A (en) New indole derivatives, process for preparing them and pharmaceutical compositions containing them
AU4930797A (en) New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them
ES485967A1 (es) Un procedimiento para la preparacion de nuevos derivados heterociclicos de cumarina
SU1014250A1 (ru) Гидрохлорид 3-(2-морфолиноэтилтио)-1,2,4-триазино (6,5-b) индола, обладающий противогипоксической и противовоспалительной активностью
GB1005876A (en) Benzenesulphonyl-urea derivatives and a process for their manufacture
JPS5649360A (en) 2-oxoquinoline derivative